Search

Author/Creator Durand, Frederick

1. 226 Summary of baricitinib effect on patient-reported outcomes (PROs) in methotrexate-inadequate responder patient population. (25th April 2018)

Authors:
Dougados, Maxime; Fautrel, Bruno J; Van De Laar, Mart A F J; Kirkham, Bruce; Alten, Rieke; Cseuz, Regina; Smolen, Josef S; Sanchez-Burson, Juan; Bird, Paul; Scheinberg, Morton; Van Den Bosch, Filip; Barry, Jane; Durand, Frederick; Zhu, Baojin; De Leonardis, Francesco; Taylor, Peter C
Journal:
Rheumatology
Issue:
Volume 57(2018)Supplement 3
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy and safety data based on historical or pre-existing conditions at baseline for patients with active rheumatoid arthritis who were treated with baricitinib. Issue 8 (6th August 2019)

Authors:
Combe, Bernard; Balsa, Alejandro; Sarzi-Puttini, Piercarlo; Tony, Hans-Peter; de la Torre, Inmaculada; Rogai, Veronica; Durand, Frederick; Witt, Sarah; Zhong, Jinglin; Dougados, Maxime
Journal:
Annals of the rheumatic diseases
Issue:
Volume 78:Issue 8(2019)
Page Start:
1135
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Efficacy and safety data based on historical or pre-existing conditions at baseline for patients with active rheumatoid arthritis who were treated with baricitinib. Issue 8 (6th March 2019)

Authors:
Combe, Bernard; Balsa, Alejandro; Sarzi-Puttini, Piercarlo; Tony, Hans-Peter; de la Torre, Inmaculada; Rogai, Veronica; Durand, Frederick; Witt, Sarah; Zhong, Jinglin; Dougados, Maxime
Journal:
Annals of the rheumatic diseases
Issue:
Volume 78:Issue 8(2019)
Page Start:
1135
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search